Literature DB >> 1903483

Purification and characterization of adenylyl cyclase from Bacillus anthracis.

S H Leppla.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903483     DOI: 10.1016/0076-6879(91)95162-d

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  17 in total

1.  Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor.

Authors:  Vibha Chauhan; Rakesh Bhatnagar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 2.  Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors.

Authors:  Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

3.  Control of anthrax toxin gene expression by the transition state regulator abrB.

Authors:  Elke Saile; Theresa M Koehler
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

4.  A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins.

Authors:  Andrei P Pomerantsev; Olga M Pomerantseva; Mahtab Moayeri; Rasem Fattah; Cynthia Tallant; Stephen H Leppla
Journal:  Protein Expr Purif       Date:  2011-08-07       Impact factor: 1.650

5.  Differential influence of the two Bacillus anthracis plasmids on regulation of virulence gene expression.

Authors:  A Fouet; M Mock
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen.

Authors:  P Kumar; N Ahuja; R Bhatnagar
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.

Authors:  V A Semenova; E Steward-Clark; K L Stamey; T H Taylor; D S Schmidt; S K Martin; N Marano; C P Quinn
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

8.  Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis.

Authors:  I Uchida; J M Hornung; C B Thorne; K R Klimpel; S H Leppla
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

9.  Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP.

Authors:  D L Hoover; A M Friedlander; L C Rogers; I K Yoon; R L Warren; A S Cross
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.

Authors:  Conrad P Quinn; Vera A Semenova; Cheryl M Elie; Sandra Romero-Steiner; Carolyn Greene; Han Li; Karen Stamey; Evelene Steward-Clark; Daniel S Schmidt; Elizabeth Mothershed; Janet Pruckler; Stephanie Schwartz; Robert F Benson; Leta O Helsel; Patricia F Holder; Scott E Johnson; Molly Kellum; Trudy Messmer; W Lanier Thacker; Lilah Besser; Brian D Plikaytis; Thomas H Taylor; Alison E Freeman; Kelly J Wallace; Peter Dull; Jim Sejvar; Erica Bruce; Rosa Moreno; Anne Schuchat; Jairam R Lingappa; Sandra K Martin; John Walls; Melinda Bronsdon; George M Carlone; Mary Bajani-Ari; David A Ashford; David S Stephens; Bradley A Perkins
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.